NYSE:MDTMedical Equipment
Medtronic (MDT) Leads $37 Million CoreMap Funding Round To Back AF Mapping System
Medtronic led a $37m Series C funding round for CoreMap, a company developing an atrial fibrillation mapping and ablation system.
The funding is intended to support further development and commercialization of CoreMap's AF mapping technology.
The move expands Medtronic's involvement in cardiac arrhythmia treatment solutions and electrophysiology tools.
Medtronic, NYSE:MDT, is adding fresh product pipeline news to the story investors have been watching around its cardiac portfolio. The stock...